PT Pyridam Farma Tbk (IDX:PYFA)

Market Cap	2.25T
Revenue (ttm)	1.92T
Net Income (ttm)	-330.25B
Shares Out	11.24B
EPS (ttm)	-38.91
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,393,600
Average Volume	18,081,510
Open	200.00
Previous Close	200.00
Day's Range	200.00 - 206.00
52-Week Range	89.00 - 338.00
Beta	1.37
RSI	54.82
Earnings Date	Apr 30, 2025

About PT Pyridam Farma Tbk

PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates through Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care produ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1976
• Employees: 1,943
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PYFA

Financial Performance

In 2024, PT Pyridam Farma Tbk's revenue was 1.92 trillion, an increase of 173.59% compared to the previous year's 702.07 billion. Losses were -330.25 billion, 287.5% more than in 2023.